J P Moreau - JoVE Visualize

Showing results (61-70 of 88) with videos related to

Pageof 9

Sort By:

Journal De Chirurgie|March 1, 1981

[Revascularization using the greater omentum. Results of an experimental study in dogs. Clinical perspectives (author's transl)]P Micheau, J P Moreau, J P Chavoin, et al.

The Journal of Clinical Endocrinology and Metabolism|September 16, 1999

Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomasP Jaquet, L Ouafik, A Saveanu, et al.

Molecular Pharmacology|June 1, 1993

Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptidesK Raynor, W A Murphy, D H Coy, et al.

Virus Research|December 1, 1993

Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particlesC Nicot, T Astier-Gin, E Edouard, et al.

Asia-Pacific Journal of Public Health|January 1, 1989

Hepatitis B infection in Vanuatu: age of acquisition of infection and possible routes of transmissionR Taylor, B Montaville, S Levy, et al.

Anticancer Research|November 4, 2000

Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cellsV Papadopoulos, A Kapsis, H Li, et al.

The Journal of Clinical Endocrinology and Metabolism|March 7, 2001

Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.

European Journal of Endocrinology|July 5, 2005

Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.

Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1988

[Epidemiological study of leptospirosis in New Caledonia]B Brethes, P L Puech, A Fraisse, et al.

Journal of Endocrinological Investigation|April 22, 2006

BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.

Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:

Pageof 9

Journal De Chirurgie|March 1, 1981

[Revascularization using the greater omentum. Results of an experimental study in dogs. Clinical perspectives (author's transl)]P Micheau, J P Moreau, J P Chavoin, et al.

The Journal of Clinical Endocrinology and Metabolism|September 16, 1999

Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomasP Jaquet, L Ouafik, A Saveanu, et al.

Molecular Pharmacology|June 1, 1993

Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptidesK Raynor, W A Murphy, D H Coy, et al.

Virus Research|December 1, 1993

Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particlesC Nicot, T Astier-Gin, E Edouard, et al.

Asia-Pacific Journal of Public Health|January 1, 1989

Hepatitis B infection in Vanuatu: age of acquisition of infection and possible routes of transmissionR Taylor, B Montaville, S Levy, et al.

Anticancer Research|November 4, 2000

Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cellsV Papadopoulos, A Kapsis, H Li, et al.

The Journal of Clinical Endocrinology and Metabolism|March 7, 2001

Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.

European Journal of Endocrinology|July 5, 2005

Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.

Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1988

[Epidemiological study of leptospirosis in New Caledonia]B Brethes, P L Puech, A Fraisse, et al.

Journal of Endocrinological Investigation|April 22, 2006

BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.

Pageof 9